Fierce Healthcare
DECEMBER 9, 2021
Anthem-backed Hydrogen Health rolls out virtual primary care services for insurers, employers. hlandi. Thu, 12/09/2021 - 09:01.
pharmaphorum
DECEMBER 9, 2021
Heather Barnes, external innovation lead EMEA at Johnson and Johnson Consumer Health, is a scientist who is truly passionate about consumer health. With her background in biochemistry and eye for identifying innovation trends, the future is bright at Johnson & Johnson Innovation. After making her way from early-stage drug development research to her current role, Heather got straight to work on creating sustainable collaborations that made life better for people and their families.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
DECEMBER 9, 2021
AHA, AMA sue Biden admin to challenge surprise billing arbitration process. pminemyer. Thu, 12/09/2021 - 12:17.
pharmaphorum
DECEMBER 9, 2021
Post-pandemic, post-Brexit Britain must create a regulatory framework that both defines and aligns with international standards, or risk being left behind. If the UK creates regulatory frameworks that drastically diverge from those of its “science allies”, it could become a late – or even no – launch market for new treatments. The need for companies to make multiple dossiers and submissions could lead to “profound implications for UK patients needing access to innovative and novel therapies”, sa
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
DECEMBER 9, 2021
CVS Health projects at least $304B in revenue for 2022. pminemyer. Thu, 12/09/2021 - 15:57.
Roots Analysis
DECEMBER 9, 2021
The epidermal growth factor receptor (EGFR is a tumor resistance biomarker which plays an essential role in the differentiation and proliferation upon activation through the binding of one of its ligands. A non-ligand-binding member of EGFR family, HER2 exerts its activity through heterodimerisation along with its other family members. HER2 is a transmembrane growth factor receptor present in the normal and malignant breast epithelial cells.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 9, 2021
Dutch biotech uniQure and partner CSL Behring are planning to file for approval of their gene therapy for haemophilia B, armed with new trial data that they say answers earlier concerns about the programme. The results are from the HOPE-B study, which was temporarily placed on a clinical hold by the FDA earlier this year after a case of liver cancer was seen in a patient treated with etranacogene dezaparvovec – subsequently deemed not to be linked to the gene therapy.
Pharma Mirror
DECEMBER 9, 2021
UAE, Abu Dhabi , Abu Dhabi has set its sights on Belgium, as a leading global pharmaceutical hub, to establish a global distribution corridor to serve the world in vaccine delivery and future life science needs. The collaboration builds on the capabilities of Abu Dhabi’s healthcare sector as a leading life sciences hub and the efforts of the HOPE Consortium in providing vaccine solutions for the world.
pharmaphorum
DECEMBER 9, 2021
A pharma company formerly led by ‘pharma bro’ Martin Shkreli has settled a long-running lawsuit with the US federal government over massive price increases for an off-patent drug treatment for people with an HIV-related disease. Vyera Pharma – known as Turing Pharma when the scandal first emerged several years ago – will pay $40 million in settlement of the charges that it raised the price of Daraprim (pyrimethamine) for toxoplasmosis, a life-threatening parasitic infection that affe
Pharma Mirror
DECEMBER 9, 2021
Combatting the pandemic has highlighted the importance of the partnership between biopharma organizations and the contract manufacturing organizations (CMOs) that must flexibly handle outsourced production, which can come suddenly and often must quickly be ramped up. For example, to meet the urgent need for COVID-19 related therapies and vaccines early in the pandemic, Thermo Fisher Scientific, a world leader in serving science with annual revenue of approximately $35 billion, had to expand its
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
DECEMBER 9, 2021
An FDA advisory committee has delivered a blow to Reata Pharma, after voting unanimously that the drugmaker’s data on bardoxolone – a drug for kidney disease – did not show it is effective. Reata is seeking approval from the US regulator for bardoxolone as a treatment for CKD caused by Alport syndrome, a rare genetic disease, after earlier clinical trial failures with the drug in CKD and diabetic kidney disease.
Outsourcing Pharma
DECEMBER 9, 2021
A leader from the advanced data and artificial intelligence specialist suggests ways to advance data collection through new tools, techniques, and thinking.
pharmaphorum
DECEMBER 9, 2021
The term ‘Rising Stars’ is often used throughout the pharma industry. In general, rising stars within a given field, are the emerging leaders that stand out amongst their peers, indicating a potential to become more influential KOLs in the future. Rising stars are also valued because they often bring fresh ideas and new approaches to medicine. The sooner that you can engage with such experts and support their work, the greater the benefit they can bring to all.
Outsourcing Pharma
DECEMBER 9, 2021
A representative shares ways that COVID-19 has impacted the already intricate pharmaceutical supply chain and offers suggestions to stay ahead of the curve.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
DECEMBER 9, 2021
Chutes & Ladders—NIH taps Tabak as acting director; Former Unilever CIO joins Mass General Brigham. hlandi. Thu, 12/09/2021 - 16:30.
Outsourcing Pharma
DECEMBER 9, 2021
The US Department of Justice has charged a former CFO and a former head of corporate communications for allegedly conducting an insider trading scheme.
Pharma Times
DECEMBER 9, 2021
In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services
pharmaphorum
DECEMBER 9, 2021
AstraZeneca’s antibody cocktail for COVID-19, now called Evushield, has become the first drug in the class to be authorised for prevention of infection by the US FDA. The long-acting antibody combination, formerly known as AZD7442 (tixagevimab and cilgavimab) has been cleared for pre-exposure prophylaxis (PrEP) of COVID-19 in adults and adolescents aged 12 and older who weigh at least 40kg and have compromised immunity.
Pharma Times
DECEMBER 9, 2021
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK
pharmaphorum
DECEMBER 9, 2021
A digital pill that records when it is taken has been shown to be highly effective at helping patients adhere to pre-exposure prophylaxis (PrEP) treatment used to protect them from contracting HIV. A pilot study, which involved 16 men who have sex with men (MSM) and a history of substance use, found that the system was 98% effective at tracking adherence to a once-daily oral PrEP regimen.
Expert insights. Personalized for you.
128 
Let's personalize your content